Author: Alyssa Lear, PharmD Introduction Recently, oral coronavirus agents showed treatment efficacy in clinical studies for outpatients with COVID-19 Goals of therapy for outpatients with
Introduction Open fracture wounds are considered high energy injuries that come with a high risk of infection due to the potential exposure of bone and
Introduction Only 0.5% to 2% of patients with a documented penicillin allergy that are administered a penicillin will exhibit a hypersensitivity reaction, usually presenting as
Introduction Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become the forefront of global public health. Since the first
Introduction UTIs are most commonly caused by Enterobacteriaceae (E. coli, Proteus spp., Klebsiella spp., etc.) and other Gram-negative organisms. UTIs are classified based on risk factors (uncomplicated vs. complicated)
Introduction Urinary tract infections (UTI) affect 150 million each year, with 50-60% of women developing at least one UTI in their lifetime. Costs of these
An e-learning platform that empowers healthcare provioders with knowledge and skills so they can provide evidence-based, safe care for these types of patients.
